Amalgamated Bank’s Cabaletta Bio CABA Stock Holding History

Amalgamated Bank’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,175	Closed	-$2K	–	3028
2025 Q1	$2K	Hold	1,175	–	–	﹤0.01%	2827
2024 Q4	$3K	Hold	1,175	–	–	﹤0.01%	2834
2024 Q3	$6K	Hold	1,175	–	–	﹤0.01%	2677
2024 Q2	$9K	Hold	1,175	–	–	﹤0.01%	2494
2024 Q1	$20K	Sell	1,175 -3,529	-75%	-$75.7K	﹤0.01%	2118
2023 Q4	$107K	Buy	4,704 +56	+1%	+$942	﹤0.01%	1973
2023 Q3	$71K	Buy	4,648 +922	+25%	+$12.6K	﹤0.01%	2116
2023 Q2	$48K	Buy	+3,726	New	+$40.4K	﹤0.01%	2336

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Amalgamated Bank's CABA Position: Q2 2025 in Review

Amalgamated Bank sold out of Cabaletta Bio (CABA) in Q2 2025, closing a stake of 1,175 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in CABA in Q2 2023 and held it in 8 quarters. The position peaked at $107K in Q4 2023. 86 funds tracked by Wall St. Rank hold CABA as of Q2 2025.

Amalgamated Bank reported no remaining Cabaletta Bio position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 1,175 Cabaletta Bio shares in Q2 2025, an estimated $2K.
Amalgamated Bank first reported a position in Cabaletta Bio in Q2 2023 and held it in 8 quarters.
Amalgamated Bank's Cabaletta Bio position peaked at $107K in Q4 2023.
86 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.